Add bettinonthebounce to that list of aliases. It has been obvious for a long time that this pest is an Osiris shareholder and not a short seller. bettinontheloss would be more appropriate with stock picks like OSIR and ANY.
I doubt it, and besides I wouldn't want to be involved with Osiris, or anybody involved with Osiris either. That company is rotten to the core.
"This review calls into question Osiris' clinical and scientific integrity, and I believe this will ultimately be a professional embarrassment for them." Is this one of the reasons the Chief Medical Officer at Osiris was terminated recently? Was he also an embarrassment for Osiris?
Pete said he didn't want to go through a miss again. Can we assume that he lowered the bar so he can go back to beating quarterly estimates again? I don't have the answer and don't want to assume anything. A couple of months ago 2016 revenue numbers seemed conservative. Last week it appeared optimistic. In early April, 2016 guidance remained unchanged. A few weeks later it is lowered. Perhaps another long term shareholder can put a more positive spin on a quarterly statement that didn't look so positive to me. I have little doubt they will meet or beat their lowered revised numbers for the rest of the year.
The company has some work to do before the market buys 30% revenue growth. Quarter over quarter sales growth rates have been slowing for 9 months. I certainly wasn't expecting revenue for 2016 to be revised lower due to a 2 million dollar miss in the first quarter. The 25% increase in April sales over January sales should have covered most of that 2 million dollar miss. 250 salesmen and international sales expected in the second half of this year. Even if I assume nothing from Stability Biologics, this revised guidance for 2016 is troubling.
You got thumbs down because of your charming personality, not because of what you mentioned. The FDA hearing has been rescheduled for September. I was hoping to hear Petit's opinion about the REGROW Act currently in the Congress. That legislation would be greatly beneficial to MiMedx.
I don't buy what you are saying here. Pete wasn't born yesterday and I'm sure he did his due diligence before buying Stability. What you are saying now should have been pretty obvious in December. Besides Stability was a pretty small purchase.
It does seem out of character for Pete to say earlier in April that full year guidance remains unchanged, and then lower the guidance a few weeks later. The biggest positive was April sales are up 25% over January sales. That should have almost covered the first quarter shortfall already.
I'll get over it. I told you before that I wouldn't touch this stock even if I was playing with Ozark's money.
If April sales are on or ahead of schedule, then it wouldn't hurt if Pete mentions it on this conference call. I'm not sure why they chose to preannounce the revenue miss and then wait several weeks to hold the full conference call. It would have been better to get all the news out at one time. This limbo period isn't helping the share price here.
Stock in the Atlanta Braves began trading this morning. The symbol is BATRA. It opened at $36 and the stock has dropped $15 in 90 minutes. Just like the Braves! Perhaps it is a value play? If you buy stock in the Braves when they are in the cellar, then the only direction is up?
I just read the starting center fielder is on the disabled list, the starting left fielder was arrested and in jail, and the best relief pitcher broke his elbow throwing a curve ball. Ouch. That is more than just bad luck. The Braves look like a train wreck this year.
I'd still rather see a single press release and one conference call for the quarter. They have reported this way before with revenue reported first, and income reported later. It is a bit ambiguous.
I usually agree with you njbugatti but Pete mentioned that sales had improved by March. It would be vague at best to announce a revenue shortfall on March 15 before the final numbers were tallied. At the end of the day, what difference would it make if the shortfall had been announced on March 15 rather than April 10?